Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants
- 1 January 2008
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 578 (2-3) , 114-122
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Differentiating antidepressants of the future: Efficacy and safetyPharmacology & Therapeutics, 2007
- Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatmentNeuropharmacology, 2005
- Evidence that serotonin reuptake modulators increase the density of serotonin innervation in the forebrainJournal of Neurochemistry, 2005
- Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regionsInternational Journal of Neuropsychopharmacology, 2005
- The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levelsBrain Research, 2004
- Absence of hippocampal mossy fiber sprouting in transgenic mice overexpressing brain‐derived neurotrophic factorJournal of Neuroscience Research, 2001
- Relationship Between GAP‐43 Expression in the Dentate Gyrus and Synaptic Reorganization of Hippocampal Mossy Fibres in Rats Treated with Kainic AcidEuropean Journal of Neuroscience, 1997
- Synaptic Vesicle Phosphoproteins and Regulation of Synaptic FunctionScience, 1993
- Widespread Expression of BDNF But Not NT3 by Target Areas of Basal Forebrain Cholinergic NeuronsScience, 1990
- Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesiclesCell, 1985